Oxidative stress and the JNK pathway in diabetes

Hideaki Kaneto1, Taka-aki Matsuoka, Yoshihisa Nakatani

  • 1Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. kaneto@medone.med

Current Diabetes Reviews
|January 29, 2008
PubMed

Insights

The JNK pathway, activated by oxidative stress in diabetes, impairs pancreatic beta-cell function and insulin resistance. Suppressing this pathway may offer a therapeutic target for diabetes treatment.

Area of Science:

  • Diabetes research
  • Cellular signaling pathways
  • Metabolic disorders

Background:

  • Diabetic conditions induce oxidative stress and activate the JNK pathway, contributing to pancreatic beta-cell dysfunction.
  • Oxidative stress and JNK pathway activation suppress insulin gene expression and reduce PDX-1 DNA binding activity.
  • Hyperglycemia's toxic effects on beta-cells can be mitigated by antioxidants or JNK pathway suppression.

Purpose of the Study:

  • To investigate the role of the JNK pathway in beta-cell dysfunction and insulin resistance in diabetes.
  • To explore the therapeutic potential of targeting the JNK pathway for diabetes treatment.

Main Methods:

  • Examined the effects of oxidative stress and JNK pathway activation on insulin gene expression and PDX-1 DNA binding activity.
  • Investigated the impact of JNK pathway suppression on insulin resistance and glucose tolerance in obese diabetic mice.
  • Analyzed alterations in key insulin signaling molecules due to JNK pathway modification.

Main Results:

  • JNK pathway activation is linked to the deterioration of pancreatic beta-cell function and suppressed insulin gene expression.
  • Suppression of the JNK pathway protects beta-cells from hyperglycemia's toxic effects.
  • In obese diabetic mice, JNK pathway suppression improved insulin resistance and glucose tolerance.
  • JNK pathway modification altered the phosphorylation state of key insulin signaling molecules.

Conclusions:

  • The JNK pathway is critically involved in the progression of insulin resistance.
  • The JNK pathway plays a crucial role in beta-cell dysfunction observed in diabetes.
  • Targeting the JNK pathway presents a potential therapeutic strategy for managing diabetes.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...